GO:0090084 negative regulation of inclusion body assembly: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0090084 describes any process that decreases the rate, frequency, or extent of inclusion body assembly, a biological process critical for proteostasis and viral replication.
• Inclusion bodies are often liquid-like organelles formed by viral proteins, and their negative regulation can disrupt viral replication and pathogenesis.
• Key proteins involved include viral nucleoproteins (e.g., Ebola NP, measles N), host factors like SRSF7, and stress granule components that modulate assembly.
• Dysregulation of inclusion body assembly is linked to neurodegenerative diseases, cancer, and viral infections, making it a therapeutic target.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of the regulatory mechanisms.
• Advanced methods such as live-cell imaging, proteomics, and RNA-seq are essential to study inclusion body dynamics and regulation.
Description
Inclusion bodies are intracellular aggregates that form under various conditions, including viral infection and cellular stress. The process of inclusion body assembly is tightly regulated, and its negative regulation, defined by GO:0090084, encompasses any process that decreases the rate, frequency, or extent of inclusion body assembly. This regulation is crucial for maintaining cellular homeostasis and combating viral replication, as many viruses hijack inclusion body formation to replicate efficiently. Understanding the negative regulation of inclusion body assembly provides insights into host-pathogen interactions and potential therapeutic strategies. Recent studies have highlighted the role of viral proteins, such as Ebola virus nucleoprotein (NP) and measles virus N, in forming inclusion bodies that serve as replication factories. Host factors, including SRSF7 and stress granule components, also modulate these processes, underscoring the complexity of the regulatory network. This article synthesizes current knowledge on GO:0090084, covering its definition, mechanisms, key genes, disease relevance, and research methodologies.
negative regulation of inclusion body assembly At A Glance
| GO ID | GO:0090084 |
|---|---|
| GO term | negative regulation of inclusion body assembly |
| Ontology | biological_process |
| Synonym | None |
| Major function | Decreases the rate, frequency, or extent of inclusion body assembly |
| Related process | Inclusion body assembly (GO:0016236) |
| Regulates | Formation of inclusion bodies, often in viral replication or stress responses |
| Key regulators | Viral proteins (e.g., Ebola NP, measles N), host factors (e.g., SRSF7, stress granule proteins) |
| Disease relevance | Viral infections, neurodegeneration, cancer |
What Is GO:0090084?
GO:0090084, negative regulation of inclusion body assembly, is defined as any process that decreases the rate, frequency, or extent of inclusion body assembly. Inclusion body assembly itself is the aggregation, arrangement, and bonding together of a set of components to form an inclusion body. This regulation can occur at various stages, from preventing the initial nucleation of aggregates to disassembling existing inclusion bodies.
Why Is negative regulation of inclusion body assembly Important in Cell Biology?
The negative regulation of inclusion body assembly is a critical cellular process that impacts viral replication, proteostasis, and disease pathogenesis. Many viruses, such as Ebola and measles, form inclusion bodies that act as replication factories, and disrupting their assembly can inhibit viral spread. In neurodegenerative diseases, inclusion bodies like Lewy bodies are hallmarks, and understanding their regulation may lead to therapeutic interventions. Furthermore, this process is intertwined with stress granule dynamics and RNA metabolism, affecting cell survival.
• Controls viral replication by modulating inclusion body formation in infections like Ebola and measles.
• Maintains proteostasis by preventing toxic protein aggregation in neurodegenerative diseases.
• Regulates stress granule and paraspeckle assembly, influencing cellular stress responses.
• Involved in cancer biology through proteins like PML that regulate oxidative stress and metabolism.
• Provides targets for antiviral therapies by disrupting viral inclusion bodies.
• Affects RNA processing and homeostasis via factors like SRSF7.
• Plays a role in autophagy and viral replication, as seen with SFTSV nonstructural proteins.
• Can be studied using CRISPR models to dissect gene function.
• Relevant to host-pathogen interactions and immune evasion.
• Offers insights into liquid-liquid phase separation and organelle dynamics.
What Happens During negative regulation of inclusion body assembly?
Initiation of Inclusion Body Assembly
In simple terms: Inclusion bodies start to form when certain proteins clump together.
Inclusion body assembly begins with the nucleation of viral or host proteins, such as Ebola virus nucleoprotein (NP) interacting with VP35, which is essential for forming replication compartments. Measles virus N protein also forms inclusion bodies with liquid organelle properties, indicating a phase separation mechanism. These initial steps are driven by protein-protein interactions and often require specific domains, like the novel domain in Ebola NP.
Regulation by Host Factors
In simple terms: Host cells have proteins that can stop inclusion bodies from forming.
Host factors such as SRSF7 regulate nuclear body assembly and maintain homeostasis, indirectly influencing inclusion body formation. Stress granules can regulate stress-induced paraspeckle assembly, which may compete with or modulate inclusion body assembly pathways. Additionally, promyelocytic leukemia protein (PML) is involved in oxidative stress responses and metabolism, potentially affecting aggregation processes.
Viral Interference with Regulation
In simple terms: Viruses can bypass the cell's attempts to stop inclusion bodies.
Viruses like Ebola and measles encode proteins that promote inclusion body formation despite negative regulatory mechanisms. For instance, Ebola VP35 interaction with NP is crucial for inclusion body formation and RNA synthesis, and disrupting this interaction reduces inclusion bodies. Similarly, measles virus forms inclusion bodies that resist cellular clearance, aiding viral replication. SFTSV nonstructural proteins induce autophagy via vimentin interaction, which may counteract negative regulation to promote viral replication.
Disassembly and Clearance
In simple terms: Cells can break down inclusion bodies to prevent damage.
Negative regulation can involve active disassembly of inclusion bodies through autophagy or proteasomal degradation. For example, SFTSV nonstructural proteins induce autophagy, which could either promote or inhibit inclusion body assembly depending on context. In some cases, host proteins like PML may facilitate clearance of aggregates, linking to oxidative stress pathways.
Impact on Cellular Homeostasis
In simple terms: Balancing inclusion body formation is key to cell health.
The negative regulation of inclusion body assembly is vital for preventing toxic aggregation. Dysregulation can lead to neurodegenerative diseases or enhanced viral replication. For instance, impaired regulation may contribute to Lewy body formation in Parkinson's disease. Conversely, inhibiting inclusion body assembly can suppress viral replication, as seen with Ebola and measles.
Key Genes Involved in GO:0090084 negative regulation of inclusion body assembly
The following genes and proteins are key players in the negative regulation of inclusion body assembly, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Ebola NP | Forms inclusion bodies; interacts with VP35 | Target for antiviral development; studied via KO and point mutations |
| VP35 | Essential for Ebola inclusion body formation and RNA synthesis | Regulates NP function; potential drug target |
| Measles N | Forms liquid-like inclusion bodies | Model for phase separation; KO reduces viral replication |
| SRSF7 | Regulates nuclear body assembly and homeostasis | Involved in RNA processing; KO affects cell viability |
| Stress granule proteins | Modulate paraspeckle assembly under stress | Link to inclusion body regulation; studied via imaging |
| PML | Regulates oxidative stress and metabolism | Tumor suppressor; affects aggregation; KO models available |
| Vimentin | Interacts with SFTSV nonstructural proteins | Promotes autophagy and viral replication; KO reduces infection |
| SFTSV NSs | Induces autophagy to promote replication | Viral factor; targets for inhibition |
| EHV1 histones | Mobilized within replication compartments | Role in herpesvirus replication; KO studies |
| RSV proteins | Overcome host innate immunity | Inclusion body formation in RSV; vaccine targets |
| Autophagy proteins | Clear inclusion bodies | Regulate aggregation; KO affects viral replication |
| Chaperones | Assist protein folding; prevent aggregation | Negative regulators; overexpression studies |
| Ubiquitin-proteasome components | Degrade misfolded proteins | Regulate inclusion body clearance; KO models |
| RNA-binding proteins | Modulate RNA metabolism and aggregation | SRSF7 and others; KO and knock-in studies |
| Cytoskeletal proteins | Provide structural support for inclusion bodies | Vimentin; KO affects viral replication |
| Innate immune sensors | Detect viral RNA and trigger responses | RSV proteins antagonize; KO studies |
| Histone variants | Regulate chromatin and replication compartments | EHV1; knock-in of tagged histones |
How Is negative regulation of inclusion body assembly Regulated?
The negative regulation of inclusion body assembly is controlled by a complex network of host and viral factors. Host proteins such as SRSF7 maintain homeostasis and prevent aberrant assembly. Stress granule components can regulate paraspeckle assembly, which may intersect with inclusion body pathways. Viral proteins like Ebola VP35 and measles N promote assembly, counteracting negative regulation. Additionally, PML is involved in oxidative stress responses that can influence aggregation. Autophagy and proteasomal degradation are key clearance mechanisms that negatively regulate inclusion bodies.
negative regulation of inclusion body assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Ebola NP | Ebola virus disease | KO of NP in viral minigenome systems; point mutations to disrupt VP35 binding |
| Measles N | Measles | KO of N in recombinant virus; live-cell imaging of inclusion bodies |
| PML | Cancer, neurodegeneration | KO and overexpression in cell lines; oxidative stress models |
| Vimentin | SFTSV infection | KO cells to assess autophagy and viral replication |
| SRSF7 | RNA processing disorders | KO and knock-in of SRSF7 to study nuclear body assembly |
Viral Infections
Inclusion bodies are hallmarks of many viral infections, including Ebola, measles, and RSV. Negative regulation of their assembly can inhibit viral replication. For example, disrupting Ebola NP-VP35 interaction reduces inclusion body formation and viral RNA synthesis. Measles virus inclusion bodies are liquid organelles that support replication, and their disassembly impairs viral spread. RSV proteins overcome innate immunity, and targeting inclusion body assembly could be antiviral.
Neurodegenerative Diseases
Inclusion bodies such as Lewy bodies in Parkinson's disease and aggresomes in other neurodegenerative disorders result from protein aggregation. Negative regulation of inclusion body assembly is crucial to prevent toxicity. PML, a protein involved in oxidative stress, may modulate aggregation and is linked to neurodegeneration. Enhancing negative regulation could be therapeutic.
Cancer
PML is a tumor suppressor that regulates oxidative stress and metabolism, and its dysfunction is associated with cancer. Inclusion body assembly pathways may affect cancer cell survival under stress. Modulating negative regulation could influence tumor progression.
Autophagy and Metabolism
SFTSV nonstructural proteins induce autophagy via vimentin to promote viral replication, highlighting a link between inclusion body regulation and autophagy. Dysregulation of autophagy can lead to metabolic disorders and contribute to disease pathogenesis.
From negative regulation of inclusion body assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate inclusion body assembly? | CRISPR KO of gene X followed by inclusion body quantification |
| Does a specific mutation in gene X affect its regulatory function? | Point mutation knock-in using CRISPR |
| How does tagging gene X affect its localization during inclusion body assembly? | Knock-in of fluorescent tag (e.g., GFP) |
| Does overexpression of gene X inhibit inclusion body formation? | Overexpression via lentiviral transduction |
| What is the interactome of gene X during infection? | Proteomics with tagged knock-in |
| Can CRISPR screening identify novel regulators? | Genome-wide CRISPR library screening |
How to Study the negative regulation of inclusion body assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Real-time dynamics of inclusion bodies | Visualize assembly/disassembly in viral infection |
| Immunofluorescence | Localization and co-localization of proteins | Confirm inclusion body formation and regulatory factors |
| Co-immunoprecipitation | Protein-protein interactions | Identify NP-VP35 interaction in Ebola |
| Mass spectrometry | Proteome-wide interaction partners | Map inclusion body interactome |
| CRISPR knockout screening | Gene function on a genome-wide scale | Identify negative regulators |
| RNA-seq | Transcriptional changes | Assess stress responses during inclusion body formation |
| Autophagy flux assays | Autophagic degradation | Measure clearance of inclusion bodies |
| FRAP | Protein mobility within inclusion bodies | Determine liquid-like properties |
Live-Cell Imaging
Live-cell imaging using fluorescently tagged proteins (e.g., GFP-tagged viral NP) allows real-time visualization of inclusion body assembly and disassembly. This method has been used to show that measles virus inclusion bodies are liquid organelles and to track Ebola NP dynamics.
Proteomics and Interactomics
Proteomic approaches such as immunoprecipitation coupled with mass spectrometry can identify protein-protein interactions critical for inclusion body regulation. For example, the interaction between Ebola NP and VP35 was mapped using such techniques. Similarly, SRSF7 interactions have been studied.
CRISPR Screening
Genome-wide CRISPR knockout screens can identify host genes that negatively regulate inclusion body assembly. This approach has been used to uncover regulators of viral replication and stress granule dynamics.
RNA-Seq and Transcriptomics
RNA-seq can reveal changes in gene expression associated with inclusion body formation and regulation. For instance, stress-induced paraspeckle assembly involves transcriptional changes that can be monitored by RNA-seq.
How CRISPR Can Be Used to Study GO:0090084 negative regulation of inclusion body assembly
Knockout
CRISPR knockout of candidate genes (e.g., SRSF7, PML) can determine their role in negatively regulating inclusion body assembly. For example, knocking out SRSF7 may disrupt nuclear body homeostasis and affect inclusion body formation. Similarly, knocking out PML could alter oxidative stress responses and aggregation.
Point Mutation
Introducing point mutations in viral or host genes (e.g., Ebola NP domain) can dissect specific residues required for inclusion body assembly and its regulation. This approach has been used to identify the novel domain in Ebola NP that interacts with VP35.
Knock-in
Knock-in of tagged versions of genes (e.g., GFP-tagged measles N) allows visualization of inclusion body dynamics in live cells. This technique has revealed that measles inclusion bodies are liquid organelles. Tagged knock-in of histones in EHV1 has also been used to study replication compartments.
Overexpression
Overexpression of negative regulators (e.g., chaperones, PML) can suppress inclusion body formation. This is useful to test sufficiency of a gene in inhibiting assembly. Overexpression of viral proteins can also overwhelm regulatory mechanisms.
How EDITGENE Supports negative regulation of inclusion body assembly Research
Researchers studying negative regulation of inclusion body assembly-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. CRISPR-based models provide a robust way to establish causality and dissect molecular mechanisms.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of inclusion body assembly research.
Frequently Asked Questions About negative regulation of inclusion body assembly
What is GO:0090084?
GO:0090084 is a Gene Ontology term for negative regulation of inclusion body assembly, describing any process that decreases the rate, frequency, or extent of inclusion body formation.
What are inclusion bodies?
Inclusion bodies are intracellular aggregates of proteins, often formed during viral infection or stress, that can serve as replication factories or storage compartments.
What genes are involved in negative regulation of inclusion body assembly?
Key genes include SRSF7, PML, vimentin, and viral proteins like Ebola NP and measles N, which modulate assembly.
How is inclusion body assembly regulated?
It is regulated by host factors, viral proteins, stress granule components, and autophagy pathways that either promote or inhibit assembly.
Why is negative regulation of inclusion body assembly important?
It is crucial for controlling viral replication, preventing toxic protein aggregation in neurodegeneration, and maintaining cellular homeostasis.
What diseases are associated with inclusion body assembly?
Diseases include viral infections (Ebola, measles, RSV), neurodegenerative disorders (Parkinson's, Alzheimer's), and cancer.
How can CRISPR be used to study inclusion body assembly?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of genes to test their role in inclusion body regulation.
What methods are used to study inclusion body assembly?
Methods include live-cell imaging, proteomics, RNA-seq, CRISPR screening, and autophagy assays.
What is the role of PML in inclusion body assembly?
PML regulates oxidative stress and metabolism and may influence protein aggregation and inclusion body formation.
How does Ebola virus form inclusion bodies?
Ebola NP interacts with VP35 to form inclusion bodies that serve as replication compartments, and disrupting this interaction reduces assembly.
Conclusion
The negative regulation of inclusion body assembly (GO:0090084) is a vital biological process with broad implications for viral pathogenesis, neurodegeneration, and cancer. Understanding its molecular mechanisms and key regulators offers opportunities for therapeutic intervention. CRISPR-based models and advanced imaging techniques are indispensable for dissecting this process. EDITGENE provides comprehensive services to support research in this field, from knockout cell lines to bioinformatics analysis.
References
- 1. Conn KL. 2025. Equine histones are mobilized within equid alphaherpesvirus 1 (EHV1) replication compartments.. J Virol 99(12):e0158925 PMID: 41288450
- 2. Miyake T et al.. 2020. Ebola Virus Inclusion Body Formation and RNA Synthesis Are Controlled by a Novel Domain of Nucleoprotein Interacting with VP35.. J Virol 94(16) PMID: 32493824
- 3. An H et al.. 2019. Stress granules regulate stress-induced paraspeckle assembly.. J Cell Biol 218(12):4127-4140 PMID: 31636118
- 4. Königs V et al.. 2020. SRSF7 maintains its homeostasis through the expression of Split-ORFs and nuclear body assembly.. Nat Struct Mol Biol 27(3):260-273 PMID: 32123389
- 5. Van Royen T et al.. 2022. How RSV Proteins Join Forces to Overcome the Host Innate Immune Response.. Viruses 14(2) PMID: 35216012
- 6. Zhou Y et al.. 2019. Measles Virus Forms Inclusion Bodies with Properties of Liquid Organelles.. J Virol 93(21) PMID: 31375591
- 7. Liu S et al.. 2023. The SFTSV Nonstructural Proteins Induce Autophagy to Promote Viral Replication via Interaction with Vimentin.. J Virol 97(4):e0030223 PMID: 37039677
- 8. Tessier S et al.. 2017. Promyelocytic Leukemia Protein, a Protein at the Crossroad of Oxidative Stress and Metabolism.. Antioxid Redox Signal 26(9):432-444 PMID: 27758112
